Oxbridge Re Holdings Limited (OXBR) Forms $2.15 Double Bottom; Shorts at Cumberland Pharmaceuticals (CPIX) Lowered By 2.21%

Cumberland Pharmaceuticals Inc (NASDAQ:CPIX) had a decrease of 2.21% in short interest. CPIX’s SI was 119,400 shares in April as released by FINRA. Its down 2.21% from 122,100 shares previously. With 16,900 avg volume, 7 days are for Cumberland Pharmaceuticals Inc (NASDAQ:CPIX)’s short sellers to cover CPIX’s short positions. The SI to Cumberland Pharmaceuticals Inc’s float is 1.5%. The stock increased 1.42% or $0.09 during the last trading session, reaching $6.44. About 4,059 shares traded. Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) has risen 4.86% since April 14, 2017 and is uptrending. It has underperformed by 6.69% the S&P500.

Oxbridge Re Holdings Limited (OXBR) formed double bottom with $2.02 target or 6.00% below today’s $2.15 share price. Oxbridge Re Holdings Limited (OXBR) has $12.33 million valuation. The stock increased 4.88% or $0.1 during the last trading session, reaching $2.15. About 500 shares traded. Oxbridge Re Holdings Limited (NASDAQ:OXBR) has declined 61.68% since April 14, 2017 and is downtrending. It has underperformed by 73.23% the S&P500.

Since March 19, 2018, it had 1 buy, and 0 selling transactions for $2,016 activity. Another trade for 300 shares valued at $2,016 was bought by Bonner Michael.

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on acquiring, developing, and commercializing branded prescription products for hospital acute care and gastroenterology markets in the United States and internationally. The company has market cap of $100.80 million. It marketed products include Acetadote injection for the treatment of acetaminophen poisoning; Caldolor (ibuprofen) injection for the treatment of pain and fever; Kristalose (lactulose) for oral solution, a prescription laxative; Vaprisol (conivaptan) injection for treating hyponatremia; Omeclamox-Pak for the treatment of H. pylori infection and duodenal ulcer disease; and Ethyol (amifostine) for injection to treat oncology patients. It currently has negative earnings. The companyÂ’s product candidates in Phase II clinical trials comprise Hepatoren (ifetroban) injection for the treatment of hepatorenal syndrome; Boxaban (ifetroban) oral capsule for the treatment of aspirin-exacerbated respiratory disease; Vasculan (ifetroban) oral capsule for the treatment of systemic sclerosis; and Portaban for the treatment of portal hypertension.

Investors sentiment increased to 0.86 in 2017 Q4. Its up 0.22, from 0.64 in 2017Q3. It increased, as 5 investors sold Cumberland Pharmaceuticals Inc. shares while 9 reduced holdings. 3 funds opened positions while 9 raised stakes. 4.12 million shares or 0.62% less from 4.14 million shares in 2017Q3 were reported. Northern Trust holds 0% or 24,875 shares. Dimensional Fund Advsrs L P owns 888,411 shares or 0% of their US portfolio. Jpmorgan Chase And Com reported 8,378 shares. Tower Research Limited Liability (Trc) accumulated 0% or 721 shares. Ariel Invests Lc invested in 0.08% or 910,076 shares. Blackrock holds 377,217 shares. Invesco stated it has 10,500 shares. 11,000 were reported by Delta Asset Ltd Liability Com Tn. Cambridge Research Advsr, a Iowa-based fund reported 10,000 shares. Sei Company owns 2,567 shares. Vanguard Gru owns 316,237 shares or 0% of their US portfolio. Spark Invest Mngmt Lc reported 13,200 shares. Thompson Davis Communications Inc, Virginia-based fund reported 1,250 shares. Bridgeway Capital Mngmt, Texas-based fund reported 283,700 shares. Bankshares Of Ny Mellon Corporation has 20,338 shares for 0% of their portfolio.

Investors sentiment decreased to 0.67 in 2017 Q4. Its down 5.33, from 6 in 2017Q3. It worsened, as 0 investors sold Oxbridge Re Holdings Limited shares while 3 reduced holdings. 0 funds opened positions while 2 raised stakes. 317,115 shares or 50.73% less from 643,586 shares in 2017Q3 were reported. Blackrock has 622 shares for 0% of their portfolio. Creative Planning holds 14,260 shares or 0% of its portfolio. Royal Savings Bank Of Canada stated it has 50,000 shares. Moreover, Lsv Asset has 0% invested in Oxbridge Re Holdings Limited (NASDAQ:OXBR). Jaffetilchin Partners Limited holds 0.01% or 12,833 shares in its portfolio. Cutler Mngmt has 120,000 shares for 0.1% of their portfolio. Moreover, Renaissance Technology Limited Co has 0% invested in Oxbridge Re Holdings Limited (NASDAQ:OXBR). The Germany-based Deutsche Bank Ag has invested 0% in Oxbridge Re Holdings Limited (NASDAQ:OXBR). Morgan Stanley has invested 0% of its portfolio in Oxbridge Re Holdings Limited (NASDAQ:OXBR). 67,076 were accumulated by Vanguard Gru.

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Institutional Positions Chart